TG Therapeutics Inc (TGTX)

Fixed asset turnover is a financial ratio that measures how efficiently a company is using its fixed assets to generate revenue. In the case of TG Therapeutics Inc, the fixed asset turnover ratio has shown significant fluctuations over the years.

As of December 31, 2020, the fixed asset turnover ratio was 0.32, indicating that the company generated $0.32 in revenue for every dollar invested in fixed assets. This low ratio suggests that TG Therapeutics Inc was not efficiently using its fixed assets to generate revenue.

By December 31, 2021, the fixed asset turnover ratio had dramatically improved to 11.15, showing a significant increase in efficiency in utilizing fixed assets to generate revenue. This suggests that the company was able to generate $11.15 in revenue for every dollar invested in fixed assets, indicating a much higher level of productivity.

In the subsequent years, the fixed asset turnover ratio remained relatively high, with values of 9.07 as of December 31, 2022, and a whopping 2,326.81 as of December 31, 2023. Such exceptionally high ratios may be indicative of extraordinary efficiency in utilizing fixed assets to drive revenue growth, possibly due to increased sales or improved operational effectiveness.

Unfortunately, there is no data available for December 31, 2024, making it challenging to assess the current state of fixed asset turnover for TG Therapeutics Inc.

Overall, the fluctuation in the fixed asset turnover ratio for TG Therapeutics Inc suggests varying levels of efficiency over the years, with significant improvements seen in recent periods. It is essential for the company to maintain this efficiency to ensure sustainable growth and profitability in the future.

Peer comparison

Dec 31, 2024